Evidence of genetic instability in tumors and normal nearby tissues

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Geraci, Giuseppe ^a,b   D'Elia, Ida ^a   Del Gaudio, Rosanna ^a   Di Giaimo, Rossella ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENOMIC DNA; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MESSENGER RNA; TUMOR MARKER; DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER TISSUE; CASE REPORT; CLONING; COLON CANCER; GENE; GENE AMPLIFICATION; GENE MUTATION; GENE NUMBER; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; T LYMPHOCYTE; COLON; COLORECTAL TUMOR; EXON; GENE EXPRESSION REGULATION; GENETIC HETEROGENEITY; GENETICS; INTRON; METABOLISM; MUTATION; PATHOLOGY;

AGED; COLON; COLORECTAL NEOPLASMS; DNA, COMPLEMENTARY; DNA, NEOPLASM; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC HETEROGENEITY; GENOMIC INSTABILITY; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTRONS; MALE; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 77949593543     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009343     Document Type: Article

References (31)

1. Coleman WB, Tsongalis GJ (1995) Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation. Clin Chem 41: 644-57.
2. Loeb LA (2001) A mutator phenotype in cancer. Cancer Res 61: 3230-9.
3. Loeb KR, Loeb LA (2000) Significance of multiple mutations in cancer. Carcinogenesis 21: 379-85.
4. Jackson AL, Loeb LA (1998) On the origin of multiple mutations in human cancers. Semin Cancer Biol 8: 421-9.
5. Ferrari R, Berk AJ, Kurdistani SK (2009) Viral manipulation of the host epigenome for oncogenic transformation. Nat Rev Genet 10: 290-4.
6. Foresti M, Paoletti I, Mele F, Geraci G (1997) Two periods of sensitivity to mutagens in induced Mel cells with different outcomes. Mutat Res 374: 269-75.
7. Foresti M, Gaudio L, Paoletti I, Geraci G (1993) Inhibition of erythroid differentiation in MEL cells by UV irradiation. Cell cycle and DNA repair activity. Mutat Res 294: 69-75.
8. Foresti M, Gaudio L, Geraci G (1992) Selective gene mutation in MEL cells. Mutat Res 265: 195-202.
9. Nicklas JA (2006) Pseudogenes Of The Human Hprt1 Gene. Environ Mol Mutagen 47(3): 212-8.
10. Albertini RJ (2001) HPRT mutations in humans: biomarkers for mechanistic studies. Mutat Res 489: 1-16.
11. Albertini RJ, Nicklas JA, Skopek TR, Recio L, O'Neill JP (1998) Genetic instability in human T-lymphocytes. Mutat Res 400: 381-9.
12. Grant BW, Trombley LM, Hunter TC, Nicklas JA, O'Neill JP, et al. (1999) HPRT mutations in vivo in human CD 34+ hematopoietic stem cells. Mutat Res 431: 183-98.
13. Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, et al. (2002) The IARC TTP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19: 607-14.
14. Heng HH, Bremer SW, Stevens JB, Ye KJ, Liu G, et al. (2009) Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. J Cell Physiol 220: 538-47.
15. Wilson VL, Yin X, Thompson B, Wade KR, Watkins JP, et al. (2000) Oncogenic base substitution mutations in circulating leukocytes of normal individuals. Cancer Res 60: 1830-4.
16. Allegretta M, Ardell SK, Sullivan LM, Jacobson S, Mortreux F, et al. (2005) HPRT mutations, TCR gene rearrangements, and HTLV-1 integration sites define in vivo T-cell clonal lineages. Environ Mol Mutagen 45: 326-37.
17. Bielas JH, Loeb KR, Rubin BP, True LD, Loeb LA (2006) Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A 103: 18238-42.
18. Green P, Ewing B, Miller W, Thomas PJ, NISC Comparative Sequencing Program, Green ED (2003) Transcription-associated mutational asymmetry in mammalian evolution. Nat Genet 33: 514-7.
19. Majewski J (2003) Dependence of mutational asymmetry on gene-expression levels in the human genome. Am J Hum Genet 73: 688-92.
20. Mohandas T, Sparkes RS, Bishop DF, Desnick RJ, Shapiro LJ (1984) Frequency of reactivation and variability in expression of X-linked enzyme loci. Am J Hum Genet 36: 916-25.
21. Takizawa T, Meaburn KJ, Misteli T (2008) The meaning of gene positioning. Cell 135: 9-13.
22. Meaburn KJ, Misteli T (2007) Cell biology: chromosome territories. Nature 445: 379-781.
23. Fraser P, Bickmore W (2007) Nuclear organization of the genome and the potential for gene regulation. Nature 447: 413-7.
24. Turner BM (2009) Epigenetic responses to environmental change and their evolutionary implications. Phil Trans R Soc B 364: 3403-3418.
25. Vermeulen L, Todaro M, de Sousa Mello F, et al. (2008) Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 105: 13427-32.
26. Innis MA, Myambo KB, Gelfand DH, Brow MA (1998) DNA sequencing with Thermus aquaticus DNA polymerase and direct sequencing of polymerase chain reaction-amplified DNA. Proc Natl Acad Sci USA 85: 9436-40.
27. Hess ST, Blake JD, Blake RD (1994) Wide variations in neighbour-dependent substitution rates. J Mol Biol 236: 1022-1033.
28. Suzuki M, Yoshida S, Adman ET, Blank A, Loeb LA (2000) Thermus aquaticus DNA polymerase I mutants with altered fidelity. Interacting mutations in the Ohelix. J Biol Chem 275: 32728-32735.
29. You FM, Huo N, Gu YQ, Luo MC, Ma Y, et al. (2008) BatchPrimer3: a high throughput web application for PCR and sequencing primer design. BMC Bioinformatics 9: 253-266.
30. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, et al. (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-12.
31. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-6.